Table 2.
Author | Year | Sample | Type of Therapy | Criteria | Results of Therapy |
---|---|---|---|---|---|
Jiang et al. [25] | 2018 | 99 Patients: 64 probiotic 35 placebo |
Cisplatinum plus radiotherapy 70 Gy |
National Cancer Institute’s Common Terminology Criteria for Adverse Events | Reduces the severity of OM through changes in the gut microbiome |
De Sanctis et al. [26] | 2019 | 68 Patients: 32 probiotic 36 placebo |
Cisplatinum plus radiotherapy 68 Gy |
National Cancer Institute’s Common Terminology Criteria for Adverse Events | No difference between the two groups |
Mirza et al. [27] | 2022 | 46 Patients: 23 probiotic 23 placebo |
Radiotherapy with or no chemotherapy 60–70 Gy |
National Cancer Institute’s Common Terminology Criteria for Adverse Events | Reduces the severity of OM |